Вклад участника
- 20:25, 23 апреля 2024 (разн. | история) . . (+3670) . . Н Usefulness-and-also-security-involving-dupilumab-throughout-patients-using-uncontrolled-severe-CRSwNP-and-a-clinical-diagnosis-of-NSAIDERD-Is-a-result-of-2-randomized-placebocontrolled-stage-Three-or-more-tests-w (Usefulness-and-also-security-involving-dupilumab-throughout-patients-using-uncontrolled-severe-CRSwNP-and-a-clinical-diagnosis-of-NSAIDERD-Is-a-result-of-2-randomized-placebocontrolled-stage-Three-or-more-tests-w) (текущая)